Literature DB >> 14698284

NK cell and DC interactions.

Megan A Cooper1, Todd A Fehniger, Anja Fuchs, Marco Colonna, Michael A Caligiuri.   

Abstract

Recent interest has focused on interactions between natural killer (NK) cells and dendritic cells (DCs). In vitro and in vivo studies have demonstrated various effects of NK-DC interactions, including activation and cytokine production, maturation of DCs and NK-cell lysis of certain autologous DCs. These interactions are important during an immune response in vivo, however, it remains unclear where in the body NK cells and DCs might interact and whether observed in vitro crosstalk between these cell types happens in vivo. We propose evidence for at least two potential locations of in vivo interactions for human NK cells and DCs, including sites of inflammation and lymph nodes.

Entities:  

Mesh:

Year:  2004        PMID: 14698284     DOI: 10.1016/j.it.2003.10.012

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  133 in total

1.  SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa.

Authors:  R Keith Reeves; Tristan I Evans; Jacqueline Gillis; Fay E Wong; Guobin Kang; Qingsheng Li; R Paul Johnson
Journal:  J Infect Dis       Date:  2012-06-18       Impact factor: 5.226

2.  Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist.

Authors:  Thanh Nhan Nguyen Pham; Cheol Yi Hong; Jung-Joon Min; Joon-Haeng Rhee; Truc Anh Thi Nguyen; Byoung Chul Park; Deok-Hwan Yang; Young-Kyu Park; Hyeong-Rok Kim; Ik-Joo Chung; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Exp Mol Med       Date:  2010-06-30       Impact factor: 8.718

3.  Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.

Authors:  Andrea De Maria; Federica Bozzano; Claudia Cantoni; Lorenzo Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  The genetic background influences the cellular and humoral immune responses to vaccines.

Authors:  M Zeng; E Nourishirazi; E Guinet; M Nouri-Shirazi
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

Review 5.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

6.  CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection.

Authors:  R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Michelle Connole; R Paul Johnson
Journal:  Blood       Date:  2010-03-25       Impact factor: 22.113

7.  Importance of stromal determinants in the generation of dendritic and natural killer cells in the human spleen.

Authors:  D Briard; B Azzarone; D Brouty-Boyé
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

Review 8.  The innate immune system and HIV pathogenesis.

Authors:  Karla A Eger; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

9.  MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.

Authors:  Amanda R Campbell; Megan C Duggan; Lorena P Suarez-Kelly; Neela Bhave; Kallan S Opheim; Elizabeth L McMichael; Prashant Trikha; Robin Parihar; Eric Luedke; Adrian Lewis; Bryant Yung; Robert Lee; David Raulet; Susheela Tridandapani; Veronika Groh; Lianbo Yu; Vedat Yildiz; John C Byrd; Michael A Caligiuri; William E Carson
Journal:  Cancer Immunol Res       Date:  2017-07-19       Impact factor: 11.151

10.  Novel APC-like properties of human NK cells directly regulate T cell activation.

Authors:  Jacob Hanna; Tsufit Gonen-Gross; Jonathan Fitchett; Tony Rowe; Mark Daniels; Tal I Arnon; Roi Gazit; Aviva Joseph; Karoline W Schjetne; Alexander Steinle; Angel Porgador; Dror Mevorach; Debra Goldman-Wohl; Simcha Yagel; Michael J LaBarre; Jane H Buckner; Ofer Mandelboim
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.